Potentiation of the "dopa" effect in parkinsonism by a direct GABA receptor agonist

Lancet. 1984 Mar 10;1(8376):559. doi: 10.1016/s0140-6736(84)90947-4.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Anticonvulsants / administration & dosage*
  • Clinical Trials as Topic
  • Double-Blind Method
  • Drug Synergism
  • Humans
  • Levodopa / administration & dosage*
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Receptors, Cell Surface / drug effects*
  • Receptors, GABA-A
  • gamma-Aminobutyric Acid / administration & dosage
  • gamma-Aminobutyric Acid / analogs & derivatives*

Substances

  • Anticonvulsants
  • Receptors, Cell Surface
  • Receptors, GABA-A
  • progabide
  • Levodopa
  • gamma-Aminobutyric Acid